لابراتوار داروسازی دکتر عبیدی
دعبید | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 26,260 2.99
Close Price: 26,410
Income Statement
AGM
Interim
2026/04/20 Fiscal Year 2025/12/2112 Month | 2025/03/10 Fiscal Year 2024/12/2012 Month | 2024/03/05 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 144.179 Trillion | 85.933 Trillion | 66.351 Trillion | |
Total Revenues | 144.179 Trillion | 85.933 Trillion | 66.351 Trillion | |
Cost of Goods Sold | 59.99 Trillion | 38.239 Trillion | 24.962 Trillion | |
Gross Profit | 84.188 Trillion | 47.694 Trillion | 41.388 Trillion | |
General & Administrative Expenses | 23.91 Trillion | 14.352 Trillion | 9.874 Trillion | |
Net Operating Income & Expenses | -1.407 Trillion | 151.066 Billion | 32.709 Billion | |
Operating Profit (Loss) | 58.872 Trillion | 33.493 Trillion | 31.547 Trillion | |
Profit Before Tax | 51.873 Trillion | 20.278 Trillion | 25.467 Trillion | |
Tax | 4.409 Trillion | 775.569 Billion | 4.305 Trillion | |
Net Profit (Loss) After Tax | 47.465 Trillion | 19.503 Trillion | 21.163 Trillion | |
Retained Earnings at Beginning of Period | 18.772 Trillion | 20.495 Trillion | 14.995 Trillion | |
Approved Dividends — Prior Year AGM | -3.69 Trillion | -4.25 Trillion | -3.105 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -15 Trillion | -16 Trillion | -11.5 Trillion | |
Allocable Profit | 47.547 Trillion | 19.747 Trillion | 21.553 Trillion | |
Legal Reserve | 2.362 Trillion | 975.137 Billion | 1.058 Trillion | |
Approved Dividends — Current Year | 18.032 Trillion | 3.69 Trillion | 4.25 Trillion | |
Retained Earnings at End of Period | 27.152 Trillion | 15.082 Trillion | 16.245 Trillion |